WASHINGTON—A new AARP Public Policy Institute report, released today, shows that retail prices for a combined set of 754 widely used brand name, generic, and specialty prescription drugs...

CHICAGO—AARP today released new data and an infographic illustrating the impact of high prescription drug prices on Americans, specifically people living with cancer, prediabetes or diabetes,...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today after the administration announced a Notice of Proposed...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today, applauding the Senate Finance Committee’s 19-9 bipartisan...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today in support of Sen. Debbie Stabenow’s amendment on...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today, responding to the Senate Finance Committee (SFC)...

WASHINGTON—AARP released today its "AARP Asks the Candidates" video series featuring 17 presidential candidates and their plans to address high prescription drug prices, Medicare and Social...

WASHINGTON—Today, AARP announced the largest group of AARP Community Challenge grantees to date. AARP will distribute nearly $1.6 million among 159 grant winners developing “quick-action”...

WASHINGTON—AARP Foundation and the law firm of Garrison, Levin-Epstein, Fitzgerald & Pirrotti, P.C., filed a class action lawsuit on behalf of Yale University employees today, alleging that...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement in response to today’s federal court ruling on the U.S....